Affinities of human histo-blood group antigens for norovirus capsid protein complexes

Glycobiology

Volumn 25, Issue 2, 2015, Pages 170-180

  Han, Ling ^a   Kitova, Elena N ^a   Tan, Ming ^b,c   Jiang, Xi ^b,c   Pluvinage, Benjamin ^d   Boraston, Alisdair B ^d   Klassen, John S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Cincinnati Children's Hosp Med C   (Canada)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF VICTORIA   (Canada)

Author keywords

affinities; antigen; electrospray ionization mass spectrometry; norovirus

Indexed keywords

BLOOD GROUP ANTIGEN; CAPSID PROTEIN; DIMER; DISACCHARIDE; EPITOPE; OLIGOSACCHARIDE; PROTEIN VP1; TETRASACCHARIDE; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; ELECTROSPRAY MASS SPECTROMETRY; NOROVIRUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRUS CELL INTERACTION; VIRUS LIKE AGENT; CHEMISTRY; HUMAN; IMMUNOLOGY; PHYSIOLOGY; VIRION;

BLOOD GROUP ANTIGENS; CAPSID PROTEINS; HUMANS; NOROVIRUS; OLIGOSACCHARIDES; PROTEIN BINDING; VIRION;

EID: 84941059261     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu100     Document Type: Article

References (44)

1. Bereszczak JZ, Barbu IM, Tan M, Xia M, Jiang X, van Duijn E, Heck AJR. 2012. Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry. J Struct Biol. 177:273-282.
2. Bu WM, Mamedova A, Tan M, Xia M, Jiang X, Hegde RS. 2008. Structural basis for the receptor binding specificity of Norwalk virus. J Virol. 82:5340-5347.
3. Choi JM, Hutson AM, Estes MK, Prasad BVV. 2008. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci USA. 105:9175-9180.
4. Collins PM, Bum-Erdene K, Yu X, Blanchard H. 2014. Galectin-3 Interactions with Glycosphingolipids. J Mol Biol. 426:1439-1451.
5. Daniel JM, Friess SD, Rajagopalan S, Wendt S, Zenobi R. 2002. Quantitative determination of noncovalent binding interactions using soft ionization mass spectrometry. Int J Mass Spectrom. 216:1-27.
6. de Rougemont A, Ruvoen-Clouet N, Simon B, Estienney M, Elie-Caille C, Aho S, Pothier P, Le Pendu J, Boireau W, Belliot G. 2011. Qualitative and quantitative analysis of the binding of GII. 4 norovirus variants onto human blood group antigens. J Virol. 85:4057-4070.
7. El-Hawiet A, Kitova EN, Arutyunov D, Simpson DJ, Szymanski CM, Klassen JS. 2012. Quantifying ligand binding to large protein complexes using electrospray ionization mass spectrometry. Anal Chem. 84:3867-3870.
8. Fiege B, Rademacher C, Cartmell J, Kitov PI, Parra F, Peters T. 2012. Molecular details of the recognition of blood group antigens by a human norovirus as determined by STD NMR spectroscopy. Angew Chem Int Ed. 51:928-932.
9. Han L, Kitov PI, Kitova EN, TanM, Wang L, Xia M, Jiang X, Klassen JS. 2013. Affinities of recombinant norovirus P dimers for human blood group antigens. Glycobiology. 23:276-285.
10. Hansman GS, Shahzad-ul-Hussan S, McLellan JS, Chuang G-Y, Georgiev I, Shimoike T, Katayama K, Bewley CA, Kwong PD. 2012. Structural basis for norovirus inhibition and fucose mimicry by citrate. J Virol. 86:284-292.
11. Higgins MA, Ficko-Blean E, Meloncelli PJ, Lowary TL, Boraston AB. 2011. The Overall architecture and receptor binding of pneumococcal carbohydrateantigen-hydrolyzing enzymes. J Mol Biol. 411:1017-1036.
12. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WEG, et al. 2002. Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim Biophys Acta. 1572:232-254.
13. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, Morrow AL, Altaye M, Pickering LK, Newburg DS, LePendu J, et al. 2003. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: Identification of 4 distinct strain-specific patterns. J Infect Dis. 188:19-31.
14. Huang P, Farkas T, Zhong W, Thornton S, Morrow AL, Jiang X. 2005. Norovirus and histo-blood group antigens: Demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol. 79:6714-6722.
15. Hutson AM, Atmar RL, Graham DY, Estes MK. 2002. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis. 185:1335-1337.
16. Hutson AM, Atmar RL, Marcus DM, Estes MK. 2003. Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J Virol. 77:405-415.
17. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 66:6527-6532.
18. Jiang X, Zhong W, Farkas T, Huang P, Wilton N, Barrett E, Fulton D, Morrow R, Matson DO. 2002. Baculovirus expression and antigenic characterization of the capsid proteins of three Norwalk-like viruses. Arch Virol. 147:119-130.
19. Kitova EN, El-Hawiet A, Schnier PD, Klassen JS. 2012. Reliable determinations of protein-ligand interactions by direct ESI-MS measurements. Are we there yet? J Am Soc Mass Spectrom. 23:431-441.
20. Meloncelli PJ, Lowary TL. 2009. Synthesis of ABO histo-blood group type V and VI antigens. Aust J Chem. 62:558-574.
21. Meloncelli PJ, Lowary TL. 2010. Synthesis of ABO histo-blood group type I and II antigens. Carbohydr Res. 345:2305-2322.
22. Meloncelli PJ, West LJ, Lowary TL. 2011. Synthesis andNMR studies on the ABO histo-blood group antigens: Synthesis of type III and IV structures and NMR characterization of type I-VI antigens. Carbohydr Res. 346:1406-1426.
23. Oriol R. 1990. Genetic-control of the fucosylation of abh precursor chains-evidence for new epistatic interactions in different cells and tissues. J Immunogenet. 17:235-245.
24. Patel MM, Widdowson M-A, Glass RI, Akazawa K, Vinje J, Parashar UD. 2008. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis. 14:1224-1231.
25. Patenaude SI, Seto NOL, Borisova SN, Szpacenko A, Marcus SL, Palcic MM, Evans SV. 2002. The structural basis for specificity in human ABO(H) blood group biosynthesis. Nat Struct Biol. 9:685-690.
26. Prasad BVV, HardyME, Dokland T, Bella J, RossmannMG, EstesMK. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science. 286:287-290.
27. Ravn V, Dabelsteen E. 2000. Tissue distribution of histo-blood group antigens. APMIS. 108:1-28.
28. Seto NOL, PalcicMM, Compston CA, Li H, Bundle DR, Narang SA. 1997. Sequential interchange of four amino acids from blood group B to blood group A glycosyltransferase boosts catalytic activity and progressively modifies substrate recognition in human recombinant enzymes. J Biol Chem. 272:14133-14138.
29. Shang J, Piskarev VE, Xia M, Huang PW, Jiang X, Likhosherstov LM, Novikova OS, Newburg DS, Ratner DM. 2013. Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance. Glycobiology. 23:1491-1498.
30. Shoemaker GK, Soya N, Palcic MM, Klassen JS. 2008. Temperature-dependent cooperativity in donor-acceptor substrate binding to the human blood group glycosyltransferases. Glycobiology. 18:587-592.
31. Shoemaker GK, van Duijn E, Crawford SE, Uetrecht C, Baclayon M, Roos WH, Wuite GJL, Estes MK, Prasad BVV, Heck AJR. 2010. Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics. 9:1742-1751.
32. Soya N, Shoemaker GK, Palcic MM, Klassen JS. 2009. Comparative study of substrate and product binding to the human ABO(H) blood group glycosyltransferases. Glycobiology. 19:1224-1234.
33. Sun J, Kitova EN, WangW, Klassen JS. 2006. Method for distinguishing specific from nonspecific protein-ligand complexes in nanoelectrospray ionization mass spectrometry. Anal Chem. 78:3010-3018.
34. Tamminen K, Huhti L, Koho T, Lappalainen S, Hytonen VP, Vesikari T, Blazevic V. 2012. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology. 135:89-99.
35. Tan M, Fang P, Chachiyo T, Xia M, Huang P, Fang Z, JiangW, Jiang X. 2008. Noroviral P particle: Structure, function and applications in virus-host interaction. Virology. 382:115-123.
36. Tan M, Fang P, Xia M, Chachiyo T, Jiang W, Jiang X. 2011. Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology. 410:345-352.
37. Tan M, Hegde RS, Jiang X. 2004. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol. 78:6233-6242.
38. TanM, Jiang X. 2005a. Norovirus and its histo-blood group antigen receptors: An answer to a historical puzzle. Trends Microbiol. 13:285-293.
39. TanM, Jiang X. 2005b. The P domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol. 79:14017-14030.
40. Uetrecht C, Barbu IM, Shoemaker GK, van Duijn E, Heck AJR. 2011. Interrogating viral capsid assembly with ion mobility-mass spectrometry. Nat Chem. 3:126-132.
41. Wang L, Huang P, Fang H, Xia M, Zhong W, McNeal MM, Jiang X, Tan M. 2013. Polyvalent complexes for vaccine development. Biomaterials. 34:4480-4492.
42. Wang L, Xia M, Huang P, Fang H, Cao D, Meng X-J, McNeal M, Jiang X, TanM. 2014. Branched-linear and agglomerate protein polymers as vaccine platforms. Biomaterials. 35:8427-8438.
43. White LJ, Hardy ME, Estes HK. 1997. Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells. J Virol. 71:8066-8072.
44. Zdanov A, Li Y, Bundle DR, Deng SJ, Mackenzie CR, Narang SA, Young NM, Cygler M. 1994. Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1. 7-angstrom resolution. Proc Natl Acad Sci USA. 91:6423-6427.